Back to Search
Start Over
Endocan Concentration in Patients With Primary Hypertension.
- Source :
- Angiology; Jul2018, Vol. 69 Issue 6, p483-489, 7p
- Publication Year :
- 2018
-
Abstract
- Inflammation and endothelial dysfunction may play an important role in the multifactorial pathogenesis of hypertension. Endocan is also thought to play a role in cell adhesion and inflammatory disorders. The aim of the study was to compare endocan concentrations in patients with primary hypertension and healthy volunteers. There were 104 patients with hypertension (study group) and 21 healthy volunteers (control group). The correlation between endocan, catecholamines, and blood pressure control in patients with primary hypertension and the control group was analyzed. The median endocan concentration in the study group (2.03 ng/mL) was significantly higher than in the control group (1.09 ng/mL, P = .0001). Endocan concentration was correlated positively with renalase (r = .2, P = .047) and norepinephrine (r = .25, P = .02). Negative correlation was observed between endocan and body mass index (r = −.25, P = .016) and leukocyte count (r = −.36, P = .0004). The present study reports higher plasma endocan concentration in patients with treated, well-controlled primary hypertension compared with healthy volunteers. The higher endocan concentration in the study group may reflect endothelial dysfunction in this population. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 00033197
- Volume :
- 69
- Issue :
- 6
- Database :
- Complementary Index
- Journal :
- Angiology
- Publication Type :
- Academic Journal
- Accession number :
- 129890070
- Full Text :
- https://doi.org/10.1177/0003319717736158